Robert Olson, Professor, Division Head of Radiation Oncology at The University of British Columbia, shared a post on LinkedIn:
“At BC Cancer – Centre for the North, in Prince George, BC, we may be the smallest centre in the BC Cancer network, but we punch well above our weight. We serve a small population of roughly 300,000 people, but across nearly 600,000 square km of Northern BC. Despite our size, our academic footprint is distinctly international.
In the current issue of The Lancet Oncology our team is proud to be co-authors on three major international collaborations:
WOLVERINE
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration.
ReCOG
Reirradiation Collaborative Group consensus on standards for dose evaluation and reporting in patients receiving multiple courses of radiation therapy, an AAPM, ACRO, ASTRO, CARO, COMP, CADRA, CPQR, ESTRO, and NRG endorsed statement and International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression: recommendations for definitions, reporting items, and study endpoints for clinical trials and audits.
This is what academic oncology can look like in a smaller, rural centre: collaborative, rigorous, and globally connected. If you are interested in combining high-impact research with meaningful regional cancer care, consider joining our team at BC Cancer – Centre for the North.”
More posts featuring Robert Olson on OncoDaily.